Clinical trials: Lifestyle-Related Disorder
Attention Deficit Hyperactivity Disorder
Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents)
The purpose of this study is to evaluate the effects of videogame-like digital therapy on attentional functioning and symptoms in adolescents ages 13-17 diagnosed with ADHD
- Trial name
- NCT04897074
- Testing
- AKL-T01
- Where
- 14 sites in United States
- Volunteers
- 165 people
- Sponsor
- Akili Interactive Labs, Inc.
ADHD
Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
To evaluate the efficacy of LDX compared to placebo in adults with ADHD in the adult workplace environment (AWE) setting
- Trial name
- NCT00697515
- Testing
- LDX
- Where
- 5 sites in United States
- Volunteers
- 142 people
- Sponsor
- Shire
Attention Deficit Disorder With Hyperactivity
Computer-assisted Cognitive Rehabilitation (CACR), Placebo CACR and Psycho-stimulants in the Treatment of ADHD
Current research aimed to compare the efficacy of computer-assisted cognitive rehabilitation (CACR), stimulant drugs and Placebo CACR on executive functions and clinical symptoms of children with attention deficit/hyperactivity…
- Trial name
- NCT01675804
- Testing
- Computerized cognitive rehabilitation, Ritalin
- Where
- Iran
- Volunteers
- 34 people
- Sponsor
- Allameh Tabatabai University
Disruptive Behavior, Attention-deficit Hyperactivity
Monitoring of Sleep and Behavior of Children 3-7 Years Old Receiving Parent-Child Interaction Therapy With the Help of Artificial Intelligence
The purpose of this study is to develop an innovative wearable tracking protocol that will use Artificial Intelligence (AI) technology to monitor sleep and behavior of 3-7 year old children.
- Conditions
- Disruptive Behavior, Attention-deficit Hyperactivity, Oppositional Defiant Disorder
- Trial name
- PISTACHIo (NCT05077722)
- Testing
- Garmin
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Mayo Clinic
Schizophrenia, Schizoaffective Disorder
SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities
Although psychotic disorders typically affect less than 1% of the population, they are a significant cause of disability worldwide.
- Conditions
- Schizophrenia, Schizoaffective Disorder, Schizotypal Disorder, Acute and Transient Psychotic Disorder
- Trial name
- SUCCEED (NCT06007105)
- Testing
- SUCCEED Community-Based Intervention
- Where
- 4 sites in Malawi, Nigeria and 2 more
- Volunteers
- 425 people
- Sponsor
- London School of Hygiene and Tropical Medicine
Attention Deficit Hyperactivity Disorder (ADHD)
Classroom-based Distance Intervention for Teachers of Children With Attention Deficit Hyperactivity Disorder
The purpose of this study is to evaluate, by way of randomized controlled trial, the effectiveness of a web-based, time-flexible, and teacher-directed "Teacher Help for ADHD" program in reducing the impact of ADHD symptoms in…
- Trial name
- NCT01547702
- Testing
- Teacher Help for ADHD
- Where
- Canada
- Volunteers
- 116 people
- Sponsor
- Dalhousie University
Attention Deficit Disorder With Hyperactivity, Substance-Related Disorders
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
Adolescents with attention deficit hyperactivity disorder (ADHD) often develop substance use disorders (SUD). The purpose of this study is to evaluate the effectiveness of atomoxetine in treating adolescents dually diagnosed with…
- Trial name
- NCT00218322
- Testing
- Atomoxetine hydrochloride
- Where
- United States
- Volunteers
- 108 people
- Sponsor
- Massachusetts General Hospital
Attention-Deficit/Hyperactivity Disorder
A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
The purpose of this study is to test if the investigational medication ABT-089 is a safe and effective treatment for children with Attention-Deficit/Hyperactivity Disorder or ADHD.
- Trial name
- NCT00528697
- Testing
- ABT-089, atomoxetine
- Where
- 20 sites in United States
- Volunteers
- 278 people
- Sponsor
- AbbVie (prior sponsor, Abbott)
Chronic Lifestyle Related Disease, Diabetes
Evaluation of a Lifestyle Medicine Practice
This project will evaluate the success of the PI's lifestyle medicine practice.
- Conditions
- Chronic Lifestyle Related Disease, Diabetes, Overweight and Obesity, Dyslipidemias
- Trial name
- NCT03739034
- Testing
- Lifestyle Medicine
- Where
- United States
- Volunteers
- 71 people, healthy volunteers welcome
- Sponsor
- Ohio University
Conduct Disorders in Children
Group-based Parenting Program to Reduce Child Conduct Disorder Symptoms in Finland
According to studies, approximately 20% of children having contact with child protection services have conduct disorder. Negative parenting can make this problem even worse.
- Trial name
- NCT03239990
- Testing
- Incredible Years, Parent group supported by home visiting
- Volunteers
- 101 people, healthy volunteers welcome
- Sponsor
- Finnish Institute for Health and Welfare
ADHD Predominantly Inattentive Type
Cognitive-Behavioral Therapy for Adults With Attention-Deficit/Hyperactivity Disorder Inattentive Presentation
Using a randomized controlled design, standard treatment of group cognitive-behavioral therapy (CBT) according to the Hesslinger protocol is compared to a newly developed group treatment specifically designed for adult patients…
- Trial name
- NCT04090983
- Testing
- Cognitive-behavioral therapy (Hesslinger protocol), Cognitive-behavioral therapy (CADDI protocol)
- Where
- Sweden
- Volunteers
- 108 people
- Sponsor
- Karolinska Institutet
Behavior Problem of Childhood and Adolescence, Parent Management Training
Behavioral Parent Training With and Without AI Support for Children With Disruptive Behaviors
The goal of this clinical trial is to learn if adding an artificial intelligence (AI) application called to standard Behavioral Parent Training (BPT) helps families with children who have disruptive behavior problems.
- Conditions
- Behavior Problem of Childhood and Adolescence, Parent Management Training, Artificial Intelligence (AI), Disruptive Behaviours
- Trial name
- NCT07469215
- Testing
- Behavioral Parent Training (BPT), Behavioral Parent Training (BPT) + Support of AI app
- Where
- Spain
- Volunteers
- 40 people
- Sponsor
- Fundació Sant Joan de Déu
Attention Deficit Hyperactivity Disorder
TDCS for the Treatment of Inattention Symptoms in Adult ADHD Patients
This study aims at evaluating the efficacy and safety of a home-based tDCS device when compared to a sham stimulation for improving attention in adult ADHD patients.
- Trial name
- TUNED (NCT04003740)
- Testing
- Home-based transcranial direct current stimulation
- Where
- Brazil
- Volunteers
- 64 people
- Sponsor
- Hospital de Clinicas de Porto Alegre
ADHD, Substance Abuse
Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)
The purpose of this study is to determine the efficacy of osmotic-release methylphenidate (OROS-MPH) versus placebo for the treatment of ADHD in adolescents with SUD.
- Trial name
- NCT00264797
- Testing
- Methylphenidate (OROS-MPH)
- Where
- 12 sites in United States
- Volunteers
- 303 people
- Sponsor
- University of Cincinnati
Brain Activity
Brain Activity by Magnetoencephalography for Children
Investigate the differences in activation of brain networks during performing functional tasks for children with attention deficit hyperactivity disorder with developmental delays and typical development
- Trial name
- NCT04629482
- Testing
- Brain networks activity
- Where
- Taiwan
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Taipei Medical University
Parkinson Disease
Progression Follow up of the First-degree Relatives of Patients With REM Sleep Behavior Disorder
REM sleep behavior disorder is a novel and distinct parasomnia characterized by recurrent dream enactment behaviors (DEBs) and polysomnographic features of REM sleep without atonia (RSWA), with typical onset age at early 60's.
- Trial name
- NCT05353959
- Testing
- No intervention
- Where
- Hong Kong
- Volunteers
- 400 people, healthy volunteers welcome
- Sponsor
- Chinese University of Hong Kong
Oppositional Defiant Disorder, Conduct Disorder
Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
This study was developed in order to assess the effects of risperidone (Risperdal) as compared with placebo on cognitive-motor performance (attention, memory, and hand steadiness) and body movements.
- Conditions
- Oppositional Defiant Disorder, Conduct Disorder, Attention Deficit/Hyperactivity Disorder (ADHD), Intermittent Explosive Disorder
- Trial name
- NCT00399698
- Testing
- Risperdal
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Ohio State University
Attention Deficit Hyperactivity Disorder, ADHD
Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting
The time course of response following one dose of a new methylphenidate hydrochloride extended release capsule is studied in children 6-12 years in a simulated laboratory classroom setting.
- Trial name
- NCT01269463
- Testing
- Methylphenidate Hydrochloride Extended Release Capsule
- Where
- United States
- Volunteers
- 26 people
- Sponsor
- Rhodes Pharmaceuticals, L.P.
Conduct Disorder, Oppositional Defiant Disorder
Genetic and Clinical Correlates of Disruptive Behavior Disorder With and Without Callous-Unemotional Traits
Disruptive Behavior Disorders (DBD), such as Conduct Disorder (CD) and Oppositional Defiant Disorder (ODD), affect children and adolescents in different ways.
- Conditions
- Conduct Disorder, Oppositional Defiant Disorder, Callous Unemotional Traits
- Trial name
- GENCU 2025 (NCT07322055)
- Where
- 2 sites in Italy
- Volunteers
- 200 people
- Sponsor
- IRCCS Fondazione Stella Maris
Attention Deficit/Hyperactivity Disorder
A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD
The is a multicenter, dose-optimized, open-label, safety/ tolerability and pharmacokinetic (PK) study with Azstarys® in children 4 and 5 years of age with attention-deficit/hyperactivity disorder (ADHD).
- Trial name
- KP415P02 (NCT05721235)
- Testing
- Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
- Where
- 20 sites in United States
- Volunteers
- 123 people
- Sponsor
- Corium, Inc.
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.